EPISODE · Apr 29, 2026 · 23 MIN
Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies
from IBD Essentials · host Axel Dignaß
Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD
Embed this episode
NOW PLAYING
Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies
0:00
23:56
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Light Not Might
Danielle Day
Saving the world while Celebrating yourself...as you actually are!Light Not Might is about learning radical self-acceptance and about finding your way by getting out of your own way.Listen to conversations about health, well-being, fitness, personal growth, and genuine human connection. Light Not Might is the companion podcast to Danielle Day's "Light 10 Up!: 10 Lifestyle Essentials to Glow By" and Open Up! Yoga Teacher Training.This is a podcast for You!!! No experience necessary! ;)
ADHD Essentials
Brendan Mahan
In ADHD Essentials, Brendan Mahan, M.Ed., M.S. interviews parents, teachers and experts to get their views on ADHD in childhood, and how it affects families.
Frequently Asked Questions
How long is this episode of IBD Essentials?
This episode is 23 minutes long.
When was this IBD Essentials episode published?
This episode was published on April 29, 2026.
Can I download this IBD Essentials episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!